Gregory Lucier drives NuVasive to be the best in spine space: 5 things to know

Written by Megan Wood | August 22, 2016 | Print  |

Gregory T. Lucier is propelling San Diego-based NuVasive into a new wave of spine dominance, according to The San Diego Union-Tribune.

Here are five things to know:


1. Under Mr. Lucier's leadership, NuVasive moved its manufacturing in-house to boost margins.


2. When Mr. Lucier filled the role of CEO and chairman in March 2015, NuVasive shares traded in the mid-$40s. By August 2016, the company's stock closed at $62.97.


3. Mr. Lucier has zoned in on NuVasive's core focus of spine surgery products and procedures. To grasp its position as the "best" in spine, NuVasive has been focused on acquisitions. NuVasive bought Ellipse Technologies in January for $380 million, leveraging the latter company's MAGEC implant systems.


4. In July 2016, NuVasive purchased Biotronic NeuroNetwork for $98 million. NuVasive now owns nervous system monitoring technology, positioning the company as the largest neurophysiology company in the spine space.


5. Ultimately, Mr. Lucier wants to elevate NuVasive to provide a complete package of hardware intertwined with technology, with products eventually expanding outside of the spine sector.


More articles on devices:
Medtronic, SeaSpine, Zimmer Biomet & more: 17 key notes
Analysts update price targets of NuVasive stock — 3 quick points
DePuy Synthes, Acumed, Stryker market leaders in Japan device market: 5 takeaways

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers